1/9/20222021 Wraps Up with Multi-billion Dollar Deals: PharmaDJ

1/7/2022Junshi and DotBio to Co-develop Next-Gen Antibody Therapy with DotBody...

1/7/2022Nuance Pharma Acquires Sino Health to Strengthen Commercial Capabiliti...

1/7/2022CDE Issues the Technical Guidance for Research of New TCM Toxicology S...

1/7/2022CDE Issues the Technical Guidance for Non-Clinical Drug Dependence Res...

1/7/2022CDE Issues the Technical Guidance for Clinical Pharmacokinetic Study o...

1/7/2022CDE Issues the Technical Guidance for Human Bioavailability and Bioequ...

1/7/2022CDE Issues the Guidance Principles for Random Allocation of Drug Clini...

1/7/2022NMPA Approves MSD's Letermovir and Eli Lilly's Abemaciclib in China

1/7/2022Drug R&D and Product Registration News Digest January 2022 (1)

1/7/2022Recent Executive Moves

1/6/2022CDE Issues the Technical Guidelines for Preparing the Risk Analysis an...

1/6/2022CDE Issues the Technical Guidelines for Pharmacokinetic Study of Patie...

1/6/2022CDE Issues the Technical Guidance for Clinical Trial Protocols of Drug...

1/6/2022CDE Issues the Technical Guidance for Clinical Research of Rare Diseas...

1/6/2022NMPA Solicits Comments on the Draft of GMP's Cell Therapy Product Appe...

1/6/2022JPO Announces Initial Year Procurement Volumes and Implementation Time...

1/5/2022Junshi Biosciences Terminates Promotion Agreement with Astrazeneca

1/5/20223SBio's Sunshine Guojian and Syncromune Enter Co-development Deal for ...

1/5/2022CDE Issues the Technical Guidance for Food Impacts in New Drug R&D Pro...

1/5/2022CDE Issues the Guidelines for Clinical Studies of Crohn's Disease Drug...

1/5/2022CDE Issues the Technical Guidelines for Clinical Trials of Ulcerative ...

1/5/2022CDE Issues the Guidance Principles for Clinical Trials of Direct Antiv...

1/5/2022Review of Sino-Foreign Drug Out-licensing Deals in 2021

1/5/2022Review of Chinese Pharma In-licensing Deals in 2021

1/5/2022SMEI: Chinese Urban Chemical Drug Hospital Market Rebounded 10% in 3Qs...

1/5/2022China 2021: The NRDL Readout (PharmExec)

1/4/2022CDE Issues on the Technical Guidelines for Writing Safety Reference In...

1/4/2022NMPA Announces OTC Switch of Four Rx Drug Products

1/4/2022Santhera Enters into Exclusive License Agreement with Sperogenix for V...

Page:153/774 Total number of articles:23207: [First][<<] [151] [152] [153] [154] [155] [>>] [End]